Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Can Neuralink’s Blindsight brain chip really help the blind see? Explore the tech, trials, and reality behind Musk’s ...

Medically reviewed by Andrew Greenberg, MD Peripheral vision is what you see beyond your direct line of sight. It helps provide a complete sense of your surroundings without moving your head. Jump to ...

Optic Neuritis symptoms typically include eye redness, pain, blurred vision, and sensitivity to light. Optic Neuritis causes range from autoimmune disorders and infections to trauma and idiopathic ...

News GlobeNewswire Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond ...

It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic ...

OCS-05 demonstrates safety and efficacy in treating acute optic neuritis, receiving FDA IND clearance for clinical development in the U.S. Small sample size of only 36 patients in the Phase 2 ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic nerve in a phase 2 study. The ACUITY trial in France analyzed 33 patients ...

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in ...

It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic ...